Ilya Goldshleger, See remarks at RxSight, Inc. (RXST), sold 9,207 shares at $50.07 ($460K) on 2024-10-18, disclosed to the SEC on 2024-10-18.
Scheduled sale ($460k) by See remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.78 | 3,100 | $154K | 33.5% |
| 2 | $50.07 | 3,002 | $150K | 32.7% |
| 3 | $50.07 | 3,002 | $150K | 32.7% |
| 4 | $50.57 | 69 | $3K | 0.8% |
| 5 | $50.59 | 34 | $2K | 0.4% |
| Total | $49.98 avg | 9,207 |
| $460K |
| 100% |
| Filing → |
| RXST | SELL | 2024-11-26 | $282K | — | Filing → |
| RXST | SELL | 2024-11-18 | $364K | — | Filing → |
| RXST | SELL | 2024-11-14 | $123K | — | Filing → |